Related Experiment Video

Updated: May 23, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Therapeutic targeting of the epidermal growth factor receptor in human cancer

Nathalie S Dhomen1, John Mariadason, Niall Tebbutt

  • 1Ludwig Institute for Cancer Research, Melbourne, Australia.

Critical Reviews in Oncogenesis
|April 5, 2012
PubMed

Insights

Epidermal growth factor receptor (EGFR) is crucial in cancer development. This review explores current EGFR therapies, resistance challenges, and future targeted treatments for cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The Epidermal Growth Factor Receptor (EGFR) family, including ERBB1, ERBB2, ERBB3, and ERBB4, are type 1 receptor tyrosine kinases.
  • These receptors integrate external stimuli for cellular responses, with aberrant EGFR and ERBB2 activation implicated in human cancer development and progression.
  • EGFR's role in signal transduction and malignant phenotype development makes it a key therapeutic target in oncology.

Purpose of the Study:

  • To review current therapeutic strategies targeting EGFR in cancer treatment.
  • To discuss emerging challenges related to EGFR therapy resistance.
  • To explore how advancing EGFR biology knowledge informs novel, targeted, or alternative cancer therapies.

Main Methods:

  • Literature review of current therapeutic approaches against EGFR.
  • Analysis of emerging challenges in EGFR therapy resistance.
  • Synthesis of current knowledge on EGFR biology to identify new therapeutic strategies.

Main Results:

  • EGFR is a critical target for various cancer therapies.
  • Therapy resistance is a significant emerging challenge in EGFR-targeted treatments.
  • Increased understanding of EGFR biology is driving the development of more precise and alternative therapeutic approaches.

Conclusions:

  • EGFR-targeted therapies are vital in cancer treatment.
  • Overcoming EGFR resistance requires continuous research and development of new strategies.
  • Future cancer therapies will increasingly leverage detailed EGFR biology insights for improved efficacy.

More Related Videos

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...